Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Blouin JM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Blouin JM; Bordeaux University, INSERM, BRIC, U1312, 33076, Bordeaux, France, Biochemistry Department, CHU Bordeaux, Place Amélie Raba-Léon, Bordeaux, France., Poursac N; Rheumatology Department, CHU Bordeaux, Place Amélie Raba-Léon, Bordeaux, France., Gad S; Medical biology laboratory, Arcachon Hospital Centre, France., Richard E; Bordeaux University, INSERM, BRIC, U1312, 33076, Bordeaux, France, Biochemistry Department, CHU Bordeaux, Place Amélie Raba-Léon, Bordeaux, France.
Publikováno v:
Annales de biologie clinique [Ann Biol Clin (Paris)] 2024 Apr 19; Vol. 82 (1), pp. 112-113.
Autor:
Redonnet-Vernhet I; Univ. Bordeaux, INSERM, MRGM, U1211, F-33076 Bordeaux, France.; Service de Biochimie, Laboratoire de Biologie Médicale de Référence (LBMR) Métabolisme des acides Aminés et Métabolisme de l'hème, Groupe hospitalier Pellegrin, CHU de Bordeaux, France., Mercié P; Service de Médecine Interne et Immunologie Clinique, Groupe Hospitalier Saint-André, CHU de Bordeaux, F-33075 Bordeaux, France.; Centre de Compétence Maladies Rares Porphyries et Anémies rares du Métabolisme du fer, CHU de Bordeaux, France.; Univ. Bordeaux, INSERM, BRIC, UMR1312, F-33076 Bordeaux, France.; Laboratory of Excellence Gr-Ex, F-75015 Paris, France., Lebreton L; Service de Biochimie, Laboratoire de Biologie Médicale de Référence (LBMR) Métabolisme des acides Aminés et Métabolisme de l'hème, Groupe hospitalier Pellegrin, CHU de Bordeaux, France., Blouin JM; Service de Biochimie, Laboratoire de Biologie Médicale de Référence (LBMR) Métabolisme des acides Aminés et Métabolisme de l'hème, Groupe hospitalier Pellegrin, CHU de Bordeaux, France.; Centre de Compétence Maladies Rares Porphyries et Anémies rares du Métabolisme du fer, CHU de Bordeaux, France.; Univ. Bordeaux, INSERM, BRIC, UMR1312, F-33076 Bordeaux, France.; Laboratory of Excellence Gr-Ex, F-75015 Paris, France., Bronnimann D; Service de Médecine Interne et Maladies Infectieuses, Groupe Hospitalier Saint-André, CHU de Bordeaux, F-33075, France., Mesli S; Service de Biochimie, Laboratoire de Biologie Médicale de Référence (LBMR) Métabolisme des acides Aminés et Métabolisme de l'hème, Groupe hospitalier Pellegrin, CHU de Bordeaux, France., Guibet C; Service de Biochimie, Laboratoire de Biologie Médicale de Référence (LBMR) Métabolisme des acides Aminés et Métabolisme de l'hème, Groupe hospitalier Pellegrin, CHU de Bordeaux, France.; Centre de Compétence Maladies Rares Porphyries et Anémies rares du Métabolisme du fer, CHU de Bordeaux, France.; Univ. Bordeaux, INSERM, BRIC, UMR1312, F-33076 Bordeaux, France.; Laboratory of Excellence Gr-Ex, F-75015 Paris, France., Ribeiro E; Service de Médecine Interne et Immunologie Clinique, Groupe Hospitalier Saint-André, CHU de Bordeaux, F-33075 Bordeaux, France., Gensous N; Service de Médecine Interne et Immunologie Clinique, Groupe Hospitalier Saint-André, CHU de Bordeaux, F-33075 Bordeaux, France.; Univ-Bordeaux, CNRS UMR5164 Immunoconcept, Bordeaux, France., Duffau P; Service de Médecine Interne et Immunologie Clinique, Groupe Hospitalier Saint-André, CHU de Bordeaux, F-33075 Bordeaux, France.; Univ-Bordeaux, CNRS UMR5164 Immunoconcept, Bordeaux, France., Gouya L; Laboratory of Excellence Gr-Ex, F-75015 Paris, France.; Centre de Référence Maladies Rares Porphyries et anémies rares du métabolisme du fer, Centre Français des Porphyries, Hôpital Louis Mourier, AP-HP, Paris, France., Richard E; Service de Biochimie, Laboratoire de Biologie Médicale de Référence (LBMR) Métabolisme des acides Aminés et Métabolisme de l'hème, Groupe hospitalier Pellegrin, CHU de Bordeaux, France.; Centre de Compétence Maladies Rares Porphyries et Anémies rares du Métabolisme du fer, CHU de Bordeaux, France.; Univ. Bordeaux, INSERM, BRIC, UMR1312, F-33076 Bordeaux, France.; Laboratory of Excellence Gr-Ex, F-75015 Paris, France.
Publikováno v:
Molecular genetics and metabolism reports [Mol Genet Metab Rep] 2024 Apr 04; Vol. 39, pp. 101076. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).
Autor:
Boutin J; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, 33000 Bordeaux, France., Genevois C; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; Vivoptic Platform INSERM US 005-CNRS UAR 3427-TBM-Core, Bordeaux University, 33000 Bordeaux, France., Couillaud F; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; Vivoptic Platform INSERM US 005-CNRS UAR 3427-TBM-Core, Bordeaux University, 33000 Bordeaux, France., Lamrissi-Garcia I; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France., Guyonnet-Duperat V; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; Vect'UB, Vectorology Platform, INSERM US 005-CNRS UAR 3427-TBM-Core, Bordeaux University, 33000 Bordeaux, France., Bibeyran A; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; Vect'UB, Vectorology Platform, INSERM US 005-CNRS UAR 3427-TBM-Core, Bordeaux University, 33000 Bordeaux, France., Lalanne M; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France., Amintas S; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; CHU de Bordeaux, Tumor Biology and Tumor Bank Laboratory, 33000 Bordeaux, France., Moranvillier I; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France., Richard E; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, 33000 Bordeaux, France., Blouin JM; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, 33000 Bordeaux, France., Dabernat S; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, 33000 Bordeaux, France., Moreau-Gaudry F; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, 33000 Bordeaux, France., Bedel A; University of Bordeaux, INSERM, UMR 1312, Bordeaux Institute of Oncology, 146 Rue Léo Saignat, 33076 Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, 33000 Bordeaux, France.
Publikováno v:
Molecular therapy. Oncology [Mol Ther Oncol] 2024 Feb 08; Vol. 32 (1), pp. 200772. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
Autor:
Goudet C; Pediatric Haematology Department, Timone Enfant, Assistance Publique Hôpitaux de Marseille (APHM), F-13005 Marseille, France., Ged C; Department of Biochemistry, Groupe Hospitalier Pellegrin, CHU Bordeaux, F-33076 Bordeaux, France.; BRIC, Bordeaux Institute of Oncology, Inserm UMR1312, University of Bordeaux, 146 Rue Léo Saignat, F-33076 Bordeaux, France.; Laboratory of Excellence Gr-Ex, Institut Imagine, F-75015 Paris, France., Petit A; Pediatric Haematology Department, Timone Enfant, Assistance Publique Hôpitaux de Marseille (APHM), F-13005 Marseille, France., Desage C; Neonatology and Pediatric Haematology, CHU de Montpellier, F-34295 Montpellier, France., Mahe P; Neonatology and Pediatric Haematology, CHU de Montpellier, F-34295 Montpellier, France., Salhi A; Faculté de Médecine d'Alger, Department of Dermatology, 16010 Alger, Algeria., Harzallah I; Genetic Department, CHU de Saint-Etienne, F-42055 Saint-Etienne, France., Blouin JM; Department of Biochemistry, Groupe Hospitalier Pellegrin, CHU Bordeaux, F-33076 Bordeaux, France.; BRIC, Bordeaux Institute of Oncology, Inserm UMR1312, University of Bordeaux, 146 Rue Léo Saignat, F-33076 Bordeaux, France.; Laboratory of Excellence Gr-Ex, Institut Imagine, F-75015 Paris, France.; Centre de Compétence Maladies Rares Porphyries, Groupe Hospitalier Saint-André, CHU Bordeaux, F-33000 Bordeaux, France., Mercie P; BRIC, Bordeaux Institute of Oncology, Inserm UMR1312, University of Bordeaux, 146 Rue Léo Saignat, F-33076 Bordeaux, France.; Laboratory of Excellence Gr-Ex, Institut Imagine, F-75015 Paris, France.; Centre de Compétence Maladies Rares Porphyries, Groupe Hospitalier Saint-André, CHU Bordeaux, F-33000 Bordeaux, France.; Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Saint-André, CHU Bordeaux, F-33000 Bordeaux, France., Schmitt C; Laboratory of Excellence Gr-Ex, Institut Imagine, F-75015 Paris, France.; Centre de Recherche sur l'Inflammation, Université de Paris Cité, Inserm U1149, F-45018 Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre de Référence Maladies Rares Porphyries, Hôpital Louis Mourier, F-92400 Colombes, France., Poli A; Laboratory of Excellence Gr-Ex, Institut Imagine, F-75015 Paris, France.; Centre de Recherche sur l'Inflammation, Université de Paris Cité, Inserm U1149, F-45018 Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre de Référence Maladies Rares Porphyries, Hôpital Louis Mourier, F-92400 Colombes, France., Gouya L; Laboratory of Excellence Gr-Ex, Institut Imagine, F-75015 Paris, France.; Centre de Recherche sur l'Inflammation, Université de Paris Cité, Inserm U1149, F-45018 Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre de Référence Maladies Rares Porphyries, Hôpital Louis Mourier, F-92400 Colombes, France., Barlogis V; Pediatric Haematology Department, Timone Enfant, Assistance Publique Hôpitaux de Marseille (APHM), F-13005 Marseille, France., Richard E; Department of Biochemistry, Groupe Hospitalier Pellegrin, CHU Bordeaux, F-33076 Bordeaux, France.; BRIC, Bordeaux Institute of Oncology, Inserm UMR1312, University of Bordeaux, 146 Rue Léo Saignat, F-33076 Bordeaux, France.; Laboratory of Excellence Gr-Ex, Institut Imagine, F-75015 Paris, France.; Centre de Compétence Maladies Rares Porphyries, Groupe Hospitalier Saint-André, CHU Bordeaux, F-33000 Bordeaux, France.
Publikováno v:
Life (Basel, Switzerland) [Life (Basel)] 2024 Jan 17; Vol. 14 (1). Date of Electronic Publication: 2024 Jan 17.
Autor:
Cullot G; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France., Boutin J; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, F-33000, Bordeaux, France., Fayet S; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France., Prat F; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France., Rosier J; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France., Cappellen D; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France.; CHU de Bordeaux, Tumor Biology and Tumor Bank Laboratory, F-33000, Bordeaux, France., Lamrissi I; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France., Pennamen P; CHU de Bordeaux, department of medical genetics, F-33000, Bordeaux, France., Bouron J; CHU de Bordeaux, department of medical genetics, F-33000, Bordeaux, France., Amintas S; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France.; CHU de Bordeaux, Tumor Biology and Tumor Bank Laboratory, F-33000, Bordeaux, France., Thibault C; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France., Moranvillier I; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France., Laharanne E; CHU de Bordeaux, Tumor Biology and Tumor Bank Laboratory, F-33000, Bordeaux, France., Merlio JP; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France.; CHU de Bordeaux, Tumor Biology and Tumor Bank Laboratory, F-33000, Bordeaux, France., Guyonnet-Duperat V; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France.; Vect'UB, vectorology platform, INSERM US 005-CNRS UAR 3427-TBM-Core, Bordeaux university, Bordeaux, France., Blouin JM; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, F-33000, Bordeaux, France., Richard E; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, F-33000, Bordeaux, France., Dabernat S; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, F-33000, Bordeaux, France., Moreau-Gaudry F; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.; CHU de Bordeaux, Biochemistry Laboratory, F-33000, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr., Bedel A; Bordeaux University, INSERM, BRIC, U1312, F-33000, Bordeaux, France. aurelie.bedel@u-bordeaux.fr.; CHU de Bordeaux, Biochemistry Laboratory, F-33000, Bordeaux, France. aurelie.bedel@u-bordeaux.fr.
Publikováno v:
Nature communications [Nat Commun] 2023 Jul 10; Vol. 14 (1), pp. 4072. Date of Electronic Publication: 2023 Jul 10.
An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid.
Autor:
Dupin C; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France.; Radiotherapy Department, CHU Bordeaux, F-33000 Bordeaux, France., Sutter J; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France., Amintas S; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France.; Tumor Biology and Tumor Bank Laboratory, Bordeaux University Hospital, F-33000 Bordeaux, France., Derieppe MA; Animalerie Mutualisée, Service Commun des Animaleries, University of Bordeaux, F-33000 Bordeaux, France., Lalanne M; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France., Coulibaly S; Radiotherapy Department, CHU Bordeaux, F-33000 Bordeaux, France., Guyon J; INSERM, BPH, U1219, University of Bordeaux, F-33000 Bordeaux, France.; Service de Pharmacologie Médicale, Bordeaux University Hospital, F-33000 Bordeaux, France., Daubon T; CNRS, IBGC, UMR5095, University of Bordeaux, F-33000 Bordeaux, France., Boutin J; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France.; Biochemistry Department, Bordeaux University Hospital, F-33000 Bordeaux, France., Blouin JM; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France.; Biochemistry Department, Bordeaux University Hospital, F-33000 Bordeaux, France., Richard E; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France.; Biochemistry Department, Bordeaux University Hospital, F-33000 Bordeaux, France., Moreau-Gaudry F; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France.; Biochemistry Department, Bordeaux University Hospital, F-33000 Bordeaux, France., Bedel A; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France.; Biochemistry Department, Bordeaux University Hospital, F-33000 Bordeaux, France., Vendrely V; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France.; Radiotherapy Department, CHU Bordeaux, F-33000 Bordeaux, France., Dabernat S; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France.; Biochemistry Department, Bordeaux University Hospital, F-33000 Bordeaux, France.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Aug 31; Vol. 14 (17). Date of Electronic Publication: 2022 Aug 31.
Autor:
Bedel A; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France; CHU de Bordeaux, Bordeaux, France., Boutin J; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France; CHU de Bordeaux, Bordeaux, France., Amintas S; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France; CHU de Bordeaux, Bordeaux, France., Lamrissi-Garcia I; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France., Rousseau B; Université de Bordeaux, Bordeaux, France; Animalerie spécialisée, Université de Bordeaux, Bordeaux, France., Poglio S; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France., Brunet de la Grange P; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France; Etablissement Français du Sang-Aquitaine Limousin (EFS-AqLi), Bordeaux, France., Moranvillier I; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France., Blouin JM; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France; CHU de Bordeaux, Bordeaux, France., Richard E; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France; CHU de Bordeaux, Bordeaux, France., Moreau-Gaudry F; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France; CHU de Bordeaux, Bordeaux, France. Electronic address: francois.moreau-gaudry@u-bordeaux.fr., Dabernat S; Université de Bordeaux, Bordeaux, France; INSERM U1035, Bordeaux, France; CHU de Bordeaux, Bordeaux, France.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2021 Sep 10; Vol. 569, pp. 23-28. Date of Electronic Publication: 2021 Jul 01.
Autor:
Boutin J; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; University Hospital Bordeaux, Biochemistry Laboratory, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France., Rosier J; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France., Cappellen D; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France.; University Hospital Bordeaux, Tumor Biology and Tumor Bank Laboratory, Bordeaux, France., Prat F; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France., Toutain J; Bordeaux University, MRGM INSERM U1211, CHU de Bordeaux, Service de Génétique Médicale, Bordeaux, France., Pennamen P; Bordeaux University, MRGM INSERM U1211, CHU de Bordeaux, Service de Génétique Médicale, Bordeaux, France., Bouron J; Bordeaux University, MRGM INSERM U1211, CHU de Bordeaux, Service de Génétique Médicale, Bordeaux, France., Rooryck C; Bordeaux University, Bordeaux, France.; Bordeaux University, MRGM INSERM U1211, CHU de Bordeaux, Service de Génétique Médicale, Bordeaux, France., Merlio JP; Bordeaux University, Bordeaux, France.; University Hospital Bordeaux, Tumor Biology and Tumor Bank Laboratory, Bordeaux, France.; INSERM U1053, Bordeaux Research in Translational Oncology, Bordeaux, France., Lamrissi-Garcia I; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France., Cullot G; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France., Amintas S; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France.; University Hospital Bordeaux, Tumor Biology and Tumor Bank Laboratory, Bordeaux, France., Guyonnet-Duperat V; INSERM US 005-CNRS UMS 342-TBM-Core, Bordeaux University, Bordeaux, France., Ged C; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; University Hospital Bordeaux, Biochemistry Laboratory, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France., Blouin JM; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; University Hospital Bordeaux, Biochemistry Laboratory, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France., Richard E; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; University Hospital Bordeaux, Biochemistry Laboratory, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France., Dabernat S; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; University Hospital Bordeaux, Biochemistry Laboratory, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France., Moreau-Gaudry F; Bordeaux University, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.; University Hospital Bordeaux, Biochemistry Laboratory, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.; Laboratory of Excellence, Gr-Ex, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.; INSERM US 005-CNRS UMS 342-TBM-Core, Bordeaux University, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr., Bedel A; Bordeaux University, Bordeaux, France.; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory disorders and Cancers, Bordeaux, France.; University Hospital Bordeaux, Biochemistry Laboratory, Bordeaux, France.; Laboratory of Excellence, Gr-Ex, Bordeaux, France.
Publikováno v:
Nature communications [Nat Commun] 2021 Aug 13; Vol. 12 (1), pp. 4922. Date of Electronic Publication: 2021 Aug 13.
Autor:
Mirmiran A; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris, Poli A; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris; Assistance Publique-Hôpitaux de Paris, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes, Ged C; Université Bordeaux, INSERM, BMGIC, U1035, CHU Bordeaux, Bordeaux; Laboratory of Excellence Gr-Ex, Paris, Schmitt C; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris; Assistance Publique-Hôpitaux de Paris, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes, Lefebvre T; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris; Assistance Publique-Hôpitaux de Paris, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes, Manceau H; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris; Université de Paris, Paris; Assistance Publique-Hôpitaux de Paris, HUPNVS, Laboratoire de Biochimie, Hôpital Beaujon, Clichy, France, Daher R; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris; Assistance Publique-Hôpitaux de Paris, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes, Moulouel B; Assistance Publique-Hôpitaux de Paris, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes, Peoc'h K; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris; Université de Paris, Paris; Assistance Publique-Hôpitaux de Paris, HUPNVS, Laboratoire de Biochimie, Hôpital Beaujon, Clichy, France, Simonin S; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris; Assistance Publique-Hôpitaux de Paris, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes, Blouin JM; Université Bordeaux, INSERM, BMGIC, U1035, CHU Bordeaux, Bordeaux; Laboratory of Excellence Gr-Ex, Paris, Deybach JC; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris; Assistance Publique-Hôpitaux de Paris, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes, Nicolas G; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris, Puy H; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris; Assistance Publique-Hôpitaux de Paris, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes, Richard E; Université Bordeaux, INSERM, BMGIC, U1035, CHU Bordeaux, Bordeaux; Laboratory of Excellence Gr-Ex, Paris, Gouya L; Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris; Assistance Publique-Hôpitaux de Paris, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes; Laboratory of Excellence Gr-Ex, Paris
Publikováno v:
Haematologica [Haematologica] 2021 Mar 01; Vol. 106 (3), pp. 913-917. Date of Electronic Publication: 2021 Mar 01.